Holdings
iShares Global Healthcare ETF
As of Jun 30, 2026, iShares Global Healthcare ETF reported 108 positions worth US$3.83B. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 350K | US$420M | −21,764 | Jun 30, 2026 |
| Johnson & Johnson | 1.07M | US$271M | −65,520 | Jun 30, 2026 |
| Abbvie Inc. | 783K | US$197M | −47,445 | Jun 30, 2026 |
| Unitedhealth Group Incorporated | 407K | US$169M | −28,795 | Jun 30, 2026 |
| Merck & Company, Inc. | 1.23M | US$158M | +39,704 | Jun 30, 2026 |
| Roche Holding Ltd | 365K | US$150M | +13,064 | Jun 30, 2026 |
| Astrazeneca Plc | 774K | US$145M | +28,659 | Jun 30, 2026 |
| Novartis Ag | 914K | US$143M | −61 | Jun 30, 2026 |
| Amgen Inc. | 269K | US$97.5M | +10,555 | Jun 30, 2026 |
| Thermo Fisher Scientific Inc | 185K | US$93M | +4,876 | Jun 30, 2026 |